Seeing Is Believing
Currently out of the existing stock ratings of Tony Ren, 1 are a SELL (50%), 1 are a BUY (50%).
Analyst Tony Ren, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 0.5% achieved within 10 days. Previously, Tony Ren worked at CLSA.
Tony Ren’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 13-Jan-2022.
Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 3/1/2021. The price target of $321 was fulfilled within 10 days with a profit of $1.61 (0.5%) receiving and performance score of 0.5.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 25-Feb-2019
$260
$75.29 (40.76%)
$254
1 years 2 months 7 days ago
(13-Nov-2024)
5/9 (55.56%)
$64.55 (33.03%)
150
Buy
Since 17-Jul-2023
$288
$103.29 (55.92%)
$285
1 years 5 months 12 days ago
(08-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
Since 12-Apr-2023
$152.5
$-32.21 (-17.44%)
$164.3
1 years 6 months 11 days ago
(09-Jul-2024)
4/4 (100%)
$7.97 (5.51%)
103
Buy
Since 13-Oct-2022
$345
$160.29 (86.78%)
$350
1 years 10 months 24 days ago
(27-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
Buy
Since 14-May-2019
$319
$134.29 (72.70%)
$321
2 years 4 months 22 days ago
(29-Aug-2023)
4/10 (40%)
$105.41 (49.35%)
105
What Year was the first public recommendation made by Tony Ren?